{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-3-pro-preview",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_zinc_washout",
        "name": "Zinc Washout Period",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 21,
        "relativeTo": "First Dose"
      },
      {
        "id": "timing_exp_washout",
        "name": "Experimental Therapy Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 90,
        "relativeTo": "Screening"
      },
      {
        "id": "timing_rx_washout",
        "name": "Prescription Medication Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 14,
        "relativeTo": "Randomization"
      },
      {
        "id": "timing_otc_washout",
        "name": "OTC Medication Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 7,
        "relativeTo": "Randomization"
      },
      {
        "id": "timing_eos_visit",
        "name": "End of Study Visit Window",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 54,
        "relativeTo": "First Dose",
        "windowLower": -2,
        "windowUpper": 2
      },
      {
        "id": "timing_outpatient_dosing",
        "name": "Outpatient Dosing Window",
        "type": "At",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 0,
        "relativeTo": "Previous Visit",
        "windowLower": -1,
        "windowUpper": 1
      },
      {
        "id": "timing_meal_delay",
        "name": "Post-Dose Fasting",
        "type": "After",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 2,
        "relativeTo": "Last Dose"
      },
      {
        "id": "timing_preg_test_freq",
        "name": "Pregnancy Testing Frequency",
        "type": "Within",
        "unit": "weeks",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "Previous Visit"
      }
    ],
    "conditions": [
      {
        "id": "cond_renal_exclusion",
        "name": "Renal Failure Exclusion",
        "instanceType": "Condition",
        "description": "Exclusion criteria based on renal function",
        "text": "End-stage renal disease on dialysis (chronic kidney disease [CKD] stage 5) or creatinine clearance < 30 mL/min"
      },
      {
        "id": "cond_alcohol_abuse",
        "name": "Alcohol Abuse Exclusion",
        "instanceType": "Condition",
        "description": "Exclusion criteria based on alcohol consumption",
        "text": "Regular weekly intake of more than 14 units"
      },
      {
        "id": "cond_neutrophil_safety",
        "name": "Neutrophil Safety Threshold",
        "instanceType": "Condition",
        "description": "Safety trigger for dose interruption",
        "text": "Neutrophils < 1.0 x 10^9/L"
      },
      {
        "id": "cond_liver_safety",
        "name": "Liver Safety Threshold",
        "instanceType": "Condition",
        "description": "Safety trigger for dose interruption (Hy's Law indicators)",
        "text": "Bilirubin > 2 x ULN Accompanied by ALT > 3 x ULN"
      },
      {
        "id": "cond_heme_drop",
        "name": "Hematology Drop Threshold",
        "instanceType": "Condition",
        "description": "Safety trigger for dose reduction",
        "text": "Hemoglobin or Platelets > 30% decrease from baseline"
      },
      {
        "id": "cond_src_review",
        "name": "SRC Review Requirement",
        "instanceType": "Condition",
        "description": "Condition for dose titration",
        "text": "Safety Review Committee (SRC) will review available safety data through Day 23 for each participant"
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_titration",
        "name": "Dose Titration to 30mg",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Titration up to 30 mg/day on Day 29. Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data"
      },
      {
        "id": "trans_dose_reduction_heme",
        "name": "Dose Reduction for Hematology",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Reduce dose to previous dose level if up-titration has occurred or reduce dose to 15 mg QOD if on 15 mg QD. No further dose increase until resolution."
      },
      {
        "id": "trans_interrupt_neutro",
        "name": "Dose Interruption for Neutropenia",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Temporary interruption if Neutrophils < 1.0 x 10^9/L"
      },
      {
        "id": "trans_interrupt_liver",
        "name": "Dose Interruption for Liver Injury",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Temporary interruption if Bilirubin > 2x ULN accompanied by ALT > 3x ULN"
      },
      {
        "id": "trans_outpatient_extension",
        "name": "Outpatient Period Extension",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "text": "Outpatient Period during Treatment Period 1 may be extended up to an additional 14 days with Investigator approval"
      },
      {
        "id": "trans_post_study_care",
        "name": "Post-Study Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "text": "Transition to therapy that was discontinued before enrollment, or transition to other standard of care therapy, or continuation of ALXN1840"
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_completion",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant completes all phases including last scheduled procedure"
      },
      {
        "id": "exit_hypersensitivity",
        "name": "Discontinuation for Hypersensitivity",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Safety discontinuation"
      },
      {
        "id": "exit_infection",
        "name": "Discontinuation for Infection",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Safety discontinuation"
      },
      {
        "id": "exit_pregnancy",
        "name": "Discontinuation for Pregnancy",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Safety discontinuation"
      },
      {
        "id": "exit_lost_followup",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Administrative discontinuation"
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_titration_review",
        "name": "Titration Safety Review",
        "timepointId": "day_23_approx",
        "instanceType": "ScheduledDecisionInstance",
        "description": "SRC review of safety data through Day 23 to authorize titration to 30mg on Day 29",
        "conditionIds": [
          "cond_src_review"
        ]
      },
      {
        "id": "dec_outpatient_ext",
        "name": "Outpatient Extension Decision",
        "timepointId": "day_22_approx",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator approval to extend Outpatient Period up to 14 days"
      },
      {
        "id": "dec_rechallenge",
        "name": "Rechallenge Decision",
        "timepointId": "unscheduled",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision to rechallenge after dose interruption (Max 3 rechallenges allowed)",
        "conditionIds": [
          "cond_neutrophil_safety"
        ]
      }
    ],
    "summary": {
      "timingCount": 8,
      "conditionCount": 6,
      "transitionRuleCount": 6,
      "exitCount": 5
    }
  }
}